Kenvue’s Neutrogena and OGX Drive 5.1% Beauty Sales Growth in Q2 2026
Beauty and consumer health company Kenvue—the Johnson & Johnson spinoff currently being acquired by Kimberly-Clark in a deal valued at $40 billion—reported a 5.1% increase in Skin Health and Beauty net sales in the second quarter of 2026. The segment was the company’s fastest-growing division.
Skin Health and Beauty generated $1.11 billion in Q2 sales, supported by organic growth across every global region. Hair Care and Face Care were the standout performers, with key innovations contributing to momentum worldwide:
- OGX Pro Growth + Peptide hair care line
- Neutrogena Ultra Sheer Sun
Neutrogena also recorded improved household penetration for the third consecutive quarter.
Across the company, Kenvue reported:
- Revenue: up 3% to $3.96 billion
- Net income: $456 million
- Diluted earnings per share: up 9% to $0.24
CEO Kirk Perry said Kenvue delivered its third consecutive quarter of net and organic sales growth, with gains across every segment and region.
Analysts cited strong e-commerce momentum and sharp brand execution as important factors in the beauty division’s outperformance. The company continues to navigate restructuring and macroeconomic pressures, including tariffs and currency headwinds.
Source: Global Cosmetics News – Kenvue Reports 5.1% Growth in Skin Health and Beauty (November 4, 2026)